Results 81 to 90 of about 7,681 (214)

Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions

BMC Pulmonary Medicine, 2010
Background Tiotropium is reimbursed since March 2004 in Belgium for the treatment of Chronic Obstructive Pulmonary Disease (COPD). Questions however remain on this product's value for money.
Thiry Nancy, Devriese Stephan, Neyt Mattias, Van den Bruel Ann   +3 more
doaj   +1 more source

Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease

International Journal of COPD, 2017
Chunxue Bai,1 Masakazu Ichinose,2 Sang Haak Lee,3 Kwan Ho Lee,4 Olaf Jöns,5 Ulrich Bothner,6 Yihua Zhao,7 Roland Buhl8 1Department of Pulmonary Medicine, Shanghai Respiratory Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China;
Bai C, Ichinose M, Lee SH, Lee KH, Jöns O, Bothner U, Zhao Y, Buhl R   +7 more
doaj  

Tiotropium bromide exerts anti-inflammatory effects during resistive breathing, an experimental model of severe airway obstruction

, 2017
Dimitrios Toumpanakis,1,2 Konstantinos Loverdos,1,2 Vassiliki Tzouda,1,2 Vyronia Vassilakopoulou,1,2 Eleni Litsiou,1,2 Christina Magkou,3 Vassiliki Karavana,1,2 Michael Pieper,4 Theodoros Vassilakopoulos1,2 1First Critical Care Department, Pulmonary ...
Litsiou E, Pieper M, Magkou C, Karavana V, Loverdos K, Vassilakopoulos T, Vassilakopoulou V, Toumpanakis D, Tzouda V   +8 more
core  

Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase IIIb study

International Journal of COPD, 2017
Jutta Beier,1 Robert Mroz,2,3 Anne-Marie Kirsten,4 Ferran Chuecos,5 Esther Garcia Gil5 1insaf Respiratory Research Institute, Wiesbaden, Germany; 2Centrum Medycyny Oddechowej, 3Medical University of Białystok, Białystok, Poland; 4Pulmonary Research ...
Beier J, Mroz R, Kirsten AM, Chuecos F, Garcia Gil E   +4 more
doaj  

Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease

, 2010
Shalini Naik, Khalid M Kamal, Patricia A Keys, Thomas J MatteiDuquesne University School of Pharmacy, Pittsburgh, PA, USAObjective: To assess the cost-effectiveness of 3 treatments (tiotropium, salmeterol, and no treatment) in patients with moderate ...
Shalini Naik, Patricia A Keys, et al, Khalid M Kamal   +3 more
core  

Socioeconomic gradients in tiotropium use among adults with COPD

, 2008
Paul D Blanc1,2,3, Mark D Eisner1,2, Edward H Yelin4,5, Gillian Earnest1, John R Balmes1,2, Steven E Gregorich6, Patricia P Katz4,51Division of Occupational and Environmental Medicine, 2Division of Pulmonary and Critical Care Medicine, 4Division of ...
Edward H Yelin, Gillian Earnest, Mark D Eisner, et al, John R Balmes, Paul D Blanc   +5 more
core  

Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review.

, 2011
BACKGROUND: Interactions between spirometry and patient-reported outcomes in COPD are not well understood. This systematic review and study-level analysis investigated the relationship between changes in FEV1 and changes in health status with ...
PW, Jones, Worthy, G, Annamaria Cerulli, Jones, PW, Capkun-Niggli Gorana, Cerulli, A, Worthy Gill, Jean Bourbeau, Westwood, M, Cerulli Annamaria, Westwood Marie, Gorana Capkun-Niggli, Gill Worthy, Bourbeau, J, Paul W Jones, Capkun-Niggli, G, Jones Paul W, Bourbeau Jean, Marie Westwood   +18 more
core   +1 more source

The role of tiotropium in the management of asthma [PDF]

Asia Pacific Allergy, 2012
Asthma is a chronic respiratory disease characterized by reversible airway obstruction that is secondary to an allergic inflammation and excessive smooth muscle contraction. Cholinergic signals were known to contribute significantly to the pathophysiology of asthma.
openaire   +2 more sources

Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US

Cost Effectiveness and Resource Allocation, 2018
Background A significant minority of asthma patients remain uncontrolled despite the use of inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA).
Zafar Zafari, Mohsen Sadatsafavi, J. Mark FitzGerald, for the Canadian Respiratory Research Network   +3 more
doaj   +1 more source

Expression of Muscarinic Receptors and the Effect of Tiotropium Bromide in Aged Mouse Model of Chronic Asthma

Tuberculosis and Respiratory Diseases, 2019
Background Efficacy and safety of tiotropium bromide, a muscarinic receptor antagonist, in treatment of asthma have been reported. However, its effect on airway remodeling in chronic asthma of the elderly has not been clearly verified.
Ji Young Kang, M.D., Ph.D., In Kyoung Kim, Ph.D., Jung Hur, Ph.D., Seok Chan Kim, M.D., Ph.D., Sook Young Lee, M.D., Ph.D., Soon Seog Kwon, M.D., Ph.D., Young Kyoon Kim, M.D., Ph.D.   +6 more
doaj